Links til undersøgelser og forskning
- Reduced Pro-Inflammatory Cytokines after Eight Weeks of Low-Dose Naltrexone for Fibromyalgia
- Low‐dose naltrexone for the treatment of fibromyalgia: Findings of a small, randomized, double‐blind, placebo‐controlled, counterbalanced, crossover trial assessing daily pain levels
- Fibromyalgia Symptoms Are Reduced by Low-Dose Naltrexone: A Pilot Study
- Low-dose naltrexone for the treatment of fibromyalgia: findings of a small, randomized, double-blind, placebo-controlled, counterbalanced, crossover trial assessing daily pain levels.
- Lavdosisnaltrexon til smertebehandling
- Naltrexone Therapy for Crohn’s Disease and Ulcerative Colitis
- Safety and tolerability of low-dose naltrexone therapy in children with moderate to severe Crohn’s disease: a pilot study
- Therapy with the opioid antagonist naltrexone promotes mucosal healing in active Crohn’s disease: a randomized placebo-controlled trial
- Low dose naltrexone for induction of remission in Crohn’s disease
- Low dose naltrexone for induction of remission in Crohn’s disease
- Low dose Naltrexone for induction of remission in inflammatory bowel disease patients
- The Effect of Low-Dose Naltrexone on Medication in Inflammatory Bowel Disease: A Quasi Experimental Before-and-After Prescription Database Study
- The Effect of Low-Dose Naltrexone on Medication in Inflammatory Bowel Disease: A Quasi Experimental Before-and-After Prescription Database Study
- Reversal of Signs and Symptoms of a B-Cell Lymphoma in a Patient Using Only Low-Dose Naltrexone
- The Long-term Survival of a Patient With Pancreatic Cancer With Metastases to the Liver After Treatment With the Intravenous -Lipoic Acid/Low-Dose Naltrexone Protocol
- The opioid growth factor (OGF) and low dose naltrexone (LDN) suppress human ovarian cancer progression in mice
- Naltrexone at low doses upregulates a unique gene expression not seen with normal doses: Implications for its use in cancer therapy
- Low dose naltrexone (LDN) enhances maturation of bone marrow dendritic cells (BMDCs)
- Targeting the opioid growth factor: Opioid growth factor receptor axis for treatment of human ovarian cancer
- LDN og kræft
- LDN and Cancer
- LDN & Cancer – THE GAME CHANGER (video)
- Low Dose Naltrexone (LDN) for Cancer Treatment
- Long-term treatment with low dose naltrexone maintains stable health in patients with multiple sclerosis
- A pilot trial of low-dose naltrexone in primary progressive multiple sclerosis
- sclerosis naltrexone
- A Fresh Breakthrough by the Discoverers of LDN – Solving the Mystery of How LDN Treats Multiple Sclerosis
- Low dose naltrexone in multiple sclerosis: Effects on medication use. A quasi-experimental study
- Serum [Met5]-enkephalin levels are reduced in multiple sclerosis and restored by low-dose naltrexone
- Modulation of the OGF-OGFr pathway alters cytokine profiles in experimental autoimmune encephalomyelitis and multiple sclerosis